Dealings in securities by a director of a major subsidiary Mediclinic International Limited (Incorporated in the Republic of South Africa) (Registration number: 1983/010725/06) ISIN: ZAE000074142 Share Code: MDC (“Mediclinic” or “the Company”) DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY In compliance with the Listings Requirements of the JSE Limited, the following information is disclosed relating to the on market sale of ordinary shares in Mediclinic by a director of a major subsidiary of the Company: Director : Mr B Valodia Company : Mediclinic Southern Africa (Pty) Ltd (major subsidiary of Mediclinic International Limited) Date of transaction : 18 December 2013 Nature of transaction : On market sale of securities Class of securities : Ordinary shares Number of securities : 10 241 Selling price : R73.50 per share Total value of transaction : R752 713.50 Nature of interest : Direct beneficial Clearance obtained : Yes Stellenbosch 18 December 2013 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 Website: www.mediclinic.com Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 18/12/2013 12:09:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.